Literature DB >> 7908725

Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.

K Inenaga1, T Nagatomo, K Nakao, N Yanaihara, H Yamashita.   

Abstract

To investigate the effects of the endogenous kappa-receptor agonists dynorphin and leumorphin on neurons of the supraoptic nucleus in the rat hypothalamus, intracellular recordings were made from 62 supraoptic neurons in slice preparations. Bath application of dynorphin and leumorphin at 10(-7) M to 3 x 10(-6) M decreased the spontaneous firing rate with slight hyperpolarization of the membrane potential (-3.8 +/- 0.5 mV, mean +/- S.E.M.) but did not detectably change input resistance. The inhibitory effects were blocked by the relatively selective kappa-antagonist MR-2266. The synthetic kappa-receptor agonist U-50,488H had similar inhibitory effects on supraoptic neurons. Postsynaptic potentials evoked by electrical stimulation dorsal or dorsolateral to the supraoptic nucleus were suppressed by dynorphin and leumorphin. Morphine and [D-Ala, D-Leu]enkephalin, which are relatively selective to mu- and delta-receptors, respectively, influenced the postsynaptic potentials less. Dynorphin and leumorphin also decreased the duration of action potentials that were prolonged by either bath application of tetraethylammonium chloride at 5-10 mM or intracellular injection of Cs ions from the recording electrodes which were filled with 3 M cesium citrate. The prolongation was blocked by 1 mM MnCl2 and 2 mM CoCl2, which suggested that the components were due to voltage-dependent Ca2+ influx. The results suggest that endogenous kappa-receptor agonists inhibit neurosecretory cells of the supraoptic nucleus to suppress synaptic events and Ca2+ components of action potentials.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908725     DOI: 10.1016/0306-4522(94)90039-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus.

Authors:  Colin H Brown; Charles W Bourque
Journal:  J Physiol       Date:  2004-04-23       Impact factor: 5.182

2.  Voltage-dependent kappa-opioid modulation of action potential waveform-elicited calcium currents in neurohypophysial terminals.

Authors:  Cristina M Velázquez-Marrero; Héctor G Marrero; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  mu-opioid receptor activation inhibits N- and P-type Ca2+ channel currents in magnocellular neurones of the rat supraoptic nucleus.

Authors:  B L Soldo; H C Moises
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

4.  Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro.

Authors:  N Doi; C H Brown; H D Cohen; G Leng; J A Russell
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

5.  Local opioid inhibition and morphine dependence of supraoptic nucleus oxytocin neurones in the rat in vivo.

Authors:  M Ludwig; C H Brown; J A Russell; G Leng
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

Review 6.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

Review 7.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

8.  kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.

Authors:  C H Brown; M Ludwig; G Leng
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 9.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

10.  Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis.

Authors:  Cynthia Franklin; Lourdes Fortepiani; Tin Nguyen; Yolanda Rangel; Randy Strong; Helmut B Gottlieb
Journal:  Pharmacol Res Perspect       Date:  2015-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.